News

Company rebranding reflects the complete merger of the companies into a cohesive customer experience.

Novel technology utilizes stem cells as models for genetic disorders and enables large scale screening of small molecule drugs.

Findings show how suppression of microRNA family of molecules leads to intestinal tumors.

Collaboration to discover and develop antisense drugs for cardiovascular, metabolic and renal diseases.

Researchers at the Virginia Bioinformatics Institute have uncovered a link between the genomes of cells originating in the neural crest and development of tumors — a discovery that could lead to new ways to diagnose and treat cancer.

The companies have announced the launch of a joint precision medicine breast cancer registry.

Researchers have shown how the level of genetic chaos in tumours could help predict patients’ response to chemotherapy according to new research.

Startups selected from Spain, Oregon, and California to advance breakthrough applications.

Rice University lab identifies mutations that allow bacteria to resist antibiotics.

A recent study shows that critical aspects of this regulatory program are encoded by genomic sequence elements that were previously thought to be mere "junk DNA" with no important functions.